Gyre Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2008 | — | $57.4M | $51.2M |
| FY2009 | — | $69.0M | $83.9M |
| FY2010 | $1.3M | $91.8M | $165.9M |
| FY2011 | $2.0M | $174.3M | $107.3M |
| FY2012 | $1.1M | $-93.3M | $3.4M |
| FY2013 | $283.0K | $-103.0M | $2.8M |
| FY2014 | $0 | $-109.4M | $1.5M |
| FY2015 | — | $31.4M | $29.1M |
| FY2016 | — | $16.1M | $10.3M |
| FY2017 | — | $30.8M | $14.5M |